Skip to main content
Recall Canary
← Back to all recalls
MEDICAL DEVICE RECALLMODERATE

Philips AneurysmFlow Software

Philips is recalling AneurysmFlow software due to unreliable MAFA ratio data that may lead to incorrect clinical treatment decisions.

What to do

Clinicians should stop using the MAFA ratio feature for making clinical decisions regarding aneurysm occlusion. Contact your local Philips representative for further instructions and software updates.

Posted
Updated
Recall No.
Z-1805-2026
Agency
Firm
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Recall ID
98576
Status
ONGOING

Why it was recalled

Potential safety issue involving the Mean Aneurysm Flow Amplitude (MAFA) ratio of AneurysmFlow (Interventional Tool). Philips has determined that the MAFA ratio does not provide reliable prognostic information regarding aneurysm occlusion following Flow Diverter Stent treatment, however despite being stated in the IUF, it is being relied on for making clinical decisions.

How to identify it

UPC 00884838099272 00884838099272 00884838099272 00884838085367 00884838099272 00884838085367 00884838116801 00884838085367

Philips AneurysmFlow. Model Number: 001015.

Where it was sold

Distributed in US.

Other recent recalls from PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-06-05 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification